Skip to main content

Abstract

Objective:

Digital substance use treatment programs present an opportunity to provide nonresidential care for people with problematic substance use. In June 2021, the provincial government in Ontario provided free access to Breaking Free Online (BFO), a digital behavioral change program for people with substance use disorders.

Methods:

An observational study was conducted with retrospective data to characterize clients’ use and engagement patterns in BFO and examine changes in self-reported outcomes.

Results:

In total, 6,370 individuals registered for BFO between June 2021 and October 2022, of whom 3,650 completed the intake assessment. Most of these clients were self-referred (64%), with 37% having been referred by health service providers. More than one-half of the clients (52%) resided in Ontario West or East regions. Support for addressing problematic alcohol use was the most requested program (40%). By October 2022, about 44% of the clients had completed between one and four of 12 program strategies. Analysis revealed significant changes in pre-post scores across four validated scales (p<0.001), indicating a decrease in anxiety and depression, an increase in quality of life, an improvement in recovery progression, and a decrease in severity of symptoms associated with substance use disorders.

Conclusions:

BFO clients with higher completion rates had the most improvement across the scales used; however, clients with lower and medium completion rates also had improvements. Because of the shame and stigma associated with substance use, digital supports with low barriers to entry can help support the autonomy, privacy, and preferences of individuals seeking help for problematic substance use.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (appi.ps.20230427.ds001.pdf)

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services

History

Received: 25 August 2023
Revision received: 12 April 2024
Accepted: 16 May 2024
Published online: 10 July 2024

Keywords

  1. Alcohol and drug abuse
  2. Alcoholism
  3. Behavior therapy
  4. Digital interventions
  5. Substance use
  6. Telehealth
  7. Substance-related disorders

Authors

Affiliations

Bilal Noreen Khan, M.P.H., M.Sc. [email protected]
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Cherry Chu, M.Sc.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Janette Brual, Ph.D.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Marlena Dang-Nguyen, M.P.H.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Adetola Oladimeji, M.D., M.P.H.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Altea Kthupi, M.P.H.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Blanca Bolea-Alamañac, M.D., Ph.D.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Mina Tadrous, Pharm.D., Ph.D.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Anne O’Riordan
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Donna Rubenstein
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Kathleen Carlin
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Philip Longum
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Daryn Gibson
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).
Ibukun-Oluwa Omolade Abejirinde, M.D., Ph.D.
Women’s College Hospital Institute for Health System Solutions and Virtual Care, Toronto (Khan, Chu, Brual, Dang-Nguyen, Oladimeji, Bolea-Alamañac, Tadrous, O’Riordan, Rubenstein, Carlin, Longum, Gibson, Abejirinde); Dalla Lana School of Public Health, University of Toronto, Toronto (Khan, Kthupi, Abejirinde); Women’s College Research Institute, Toronto (Kthupi); Department of Psychiatry, University of Toronto, Toronto (Bolea-Alamañac); Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto (Tadrous); Patient Advisors Network, Toronto (O’Riordan, Rubenstein, Carlin).

Notes

Send correspondence to Mr. Khan ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

This work was supported by funding from the Ontario Ministry of Health to the Centre for Digital Health Evaluation at Women’s College Hospital, Toronto.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share